Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation (ACHIEVE)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Gail Daumit, MD, MHS, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00902694
First received: May 13, 2009
Last updated: April 23, 2014
Last verified: April 2014
  Purpose

This study will determine whether a behavioral weight loss intervention including dietary counseling and exercise is effective in helping people with serious mental illnesses lose weight.


Condition Intervention
Overweight and Obesity
Behavioral: ACHIEVE Intervention
Other: Control

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Trial Of Achieving Healthy Lifestyles In Psychiatric Rehabilitation

Resource links provided by NLM:


Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Weight loss [ Time Frame: 6 and 18 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • cycle ergometry testing/cardiorespiratory fitness [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Waist circumference [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Blood pressure [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Lipids [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Framingham cardiovascular risk score [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Health status [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]
  • Depression CES-D [ Time Frame: Measured at 6 and 18 months ] [ Designated as safety issue: No ]

Enrollment: 291
Study Start Date: April 2008
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ACHIEVE Intervention
Group and individual weight counseling and group physical activity classes for 18 months.
Behavioral: ACHIEVE Intervention
Group and individual weight loss counseling and group physical activity classes for 18 months
Control
Control arm receives group health classes quarterly with topics not related to weight
Other: Control
group health classes quarterly with topics not related to weight

Detailed Description:

The objective of this study is to perform a randomized clinical trial (ACHIEVE) to definitively test the efficacy of an innovative, practical intervention to accomplish weight loss in overweight and obese persons with SMI. This multi-site trial will enroll consumers with SMI who attend ten psychiatric rehabilitation centers in Maryland and randomize participants to the ACHIEVE intervention or control. Intervention participants will receive group and individual weight loss counseling sessions and group physical activity classes. Co-primary outcomes will be change in weight from baseline to 6 and 18 months.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Age 18 and older;

  • Overweight, defined by Body Mass Index at least 25.0 kg/m2;
  • Able and willing to give informed consent and participate in the intervention;
  • On the same psychiatric medications within the 30 days before baseline weight (dose changes allowed;)
  • Able to attend at least 2 intervention sessions per week during initial 6-month phase;

Exclusion criteria

  • Contraindication to weight loss

    • Receiving active cancer treatment (radiation/chemotherapy)
    • Liver failure
    • History of anorexia nervosa;
  • Cardiovascular event (unstable angina, myocardial infarction) within previous 6 months;
  • Prior or planned bariatric surgery;

Use of prescription weight loss medication or over-the-counter orlistat within 3 months

if participant does not agree to stop taking it;

  • Twenty pound or greater weight loss in 3 months prior to baseline, as documented by staff measurement;
  • Inability to walk to participate in exercise class;
  • Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician;
  • Alcohol or substance use disorder either: 1) active and determined to be incompatible with participation in the intervention through discussion with program staff; or 2) new abstinence from alcohol or substance use disorder in past 30 days;
  • Planning to leave rehabilitation center within 6 months or move out of geographic area within 18 months;
  • Investigator judgment (e.g., for concerns over safety, adherence or follow-up);
  • Weight greater than 400 pounds.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00902694

Locations
United States, Maryland
Prohealth
Baltimore, Maryland, United States, 21207
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Gail L. Daumit, MD, MHS Johns Hopkins School of Medicine
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Gail Daumit, MD, MHS, Gail L. Daumit, MD, MHS, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00902694     History of Changes
Other Study ID Numbers: R01 MH080964, R01MH080964, DAHBR 96-BHB, NIMH R01MH080964
Study First Received: May 13, 2009
Last Updated: April 23, 2014
Health Authority: United States: Federal Government

Keywords provided by Johns Hopkins University:
Serious Mental Illness
Weight Loss

Additional relevant MeSH terms:
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on October 01, 2014